🔴 Altria Group is trading 4% down today amid renewed FDA nicotine-cap discussion

Altria Group is trading 4% down at $65.61 after renewed discussion of potential FDA nicotine caps created fresh uncertainty around combustible cigarettes, its core business.

• Tobacco shares are falling broadly, with Altria underperforming peers.
• Recent second-quarter earnings concerns included an adjusted EPS miss and declining cigarette and nicotine-pouch volumes.
• The broader market is only modestly lower: S&P 500 down 0.08%, Nasdaq Composite down 0.38%, and Dow Jones down 0.24%, making broad weakness insufficient alone.